Cordancemedical
Mountain View, US · 3 known investors
Cordance Medical is developing NeuroAccess, a non-invasive medical device that uses low-frequency focused ultrasound and microbubbles to reversibly open the blood-brain barrier at targeted sites, enabling drug delivery and blood-based biomarker measurement. It targets brain diseases including brain cancers, Alzheimer's, Parkinson's, and epilepsy, and its device received the FDA's Breakthrough Device Designation.
Founders & leadership
RD
Ryan DittamoreCEO